U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.5073dup (p.Trp1692fs) AND multiple conditions

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 13, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002482932.9

Allele description [Variation Report for NM_000059.4(BRCA2):c.5073dup (p.Trp1692fs)]

NM_000059.4(BRCA2):c.5073dup (p.Trp1692fs)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.5073dup (p.Trp1692fs)
Other names:
5301_5302insA; p.Trp1692MetfsX3; p.Trp1692fs
HGVS:
  • NC_000013.11:g.32339428dup
  • NG_012772.3:g.28949dup
  • NM_000059.4:c.5073dupMANE SELECT
  • NP_000050.3:p.Trp1692fs
  • LRG_293:g.28949dup
  • NC_000013.10:g.32913558_32913559insA
  • NC_000013.10:g.32913565dup
  • NC_000013.10:g.32913565dupA
  • NM_000059.3:c.5073dupA
  • NM_000059.4:c.5073dup
  • NM_000059.4:c.5073dupA
  • U43746.1:n.5301_5302insA
  • p.Trp1692Metfs*3
  • p.W1692Mfs*3
  • p.W1692MfsX3
Nucleotide change:
5301insA
Protein change:
W1692fs
Links:
Breast Cancer Information Core (BIC) (BRCA2): 5301&base_change=ins A; dbSNP: rs80359479
NCBI 1000 Genomes Browser:
rs80359479
Observations:
1

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480
Name:
Breast-ovarian cancer, familial, susceptibility to, 2 (BROVCA2)
Synonyms:
Breast-ovarian cancer, familial 2
Identifiers:
MONDO: MONDO:0012933; MedGen: C2675520; Orphanet: 145; OMIM: 612555
Name:
Fanconi anemia complementation group D1
Identifiers:
MONDO: MONDO:0011584; MedGen: C1838457; OMIM: 605724
Name:
Medulloblastoma (MDB)
Synonyms:
Medulloblastoma, somatic; MEDULLOBLASTOMA PREDISPOSITION SYNDROME
Identifiers:
MONDO: MONDO:0007959; MeSH: D008527; MedGen: C0025149; Orphanet: 616; OMIM: 155255; Human Phenotype Ontology: HP:0002885
Name:
Wilms tumor 1 (WT1)
Synonyms:
Wilms tumor, somatic
Identifiers:
MONDO: MONDO:0008679; MedGen: CN033288; Orphanet: 654; OMIM: 194070
Name:
Malignant tumor of prostate
Synonyms:
Prostate cancer
Identifiers:
MONDO: MONDO:0008315; MedGen: C0376358; Orphanet: 1331; Human Phenotype Ontology: HP:0012125
Name:
Pancreatic cancer, susceptibility to, 2
Synonyms:
Pancreatic cancer 2
Identifiers:
MONDO: MONDO:0013235; MedGen: C3150546; Orphanet: 1333; OMIM: 613347
Name:
Glioma susceptibility 3 (GLM3)
Synonyms:
Glioblastoma 3
Identifiers:
MONDO: MONDO:0013093; MedGen: C2751641; Orphanet: 182067; Orphanet: 360; OMIM: 613029

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002780077Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)		Pathogenic
(May 31, 2022) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004121692Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili
criteria provided, single submitter

(ACMG Guidelines, 2015)		Pathogenic
(Nov 13, 2023) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
Latingermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002780077.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili, SCV004121692.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Latin1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 10, 2024